Myles Hume

Anti-VEGF PBS drug

Anti-VEGF remains most expensive PBS drug

The Australian government spent $55 million more on anti-VEGF macular disease therapies in 2020-21 compared to the previous year, with aflibercept (Eylea) maintaining its title as the costliest subsided drug in the country. Read more

phase out coal power RANZCO

RANZCO calls to phase out coal-fired power stations

RANZCO is among five medical colleges from across Australia and New Zealand, with more than 56,000 members, that have written to federal, state and territory leaders and energy companies calling for a plan to phase out coal-burning power stations by 2030. Read more

© All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

JOIN OUR NEWSLETTER

JOIN OUR NEWSLETTER
Close